Glaxo's Cervarix vaccine faces further US delay - Reuters
June 30th, 2008 by admin
 Canada.com |
Glaxo's Cervarix vaccine faces further US delay
Reuters - By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline Plc (GSK.L: Quote, Profile, Research, Stock Buzz) does not expect to win US approval for its key cervical cancer vaccine Cervarix until late 2009, marking a further delay for the product. GlaxoSmithKline responds to FDA's Cervarix questions Merck slips as FDA rejects wider Gardasil use |
More: continued here
Posted in Uncategorized